Skip to main content

Day: November 21, 2019

Welltec Q3 2019 Interim Report and investor conference call announcement

Company announcement no. 4/2019November 21st 2019Q3 2019 Interim Report and Investor Conference Call AnnouncementWelltec® will disclose its 2019 Q3 Interim Report and will discuss the results during an investor conference call to be held Thursday November 28th 2019 at 5 pm CET.The conference call will be available only for current and prospective bond holders, broker dealers and securities analysts and can be accessed by dialing in a few minutes before the start and informing the operator that you would like to participate in Welltec’s investor conference call.Relevant dial-in details and conference ID can be obtained by contacting bkjelmann@welltec.com and registering for the call. Registration will not be possible once the investor conference has started.The Interim Report will be made available on the “Investor Room” on Welltec’s website...

Continue reading

Endeavour Mining Completes Upsize of Ity CIL Plant and Consolidates the Ity Mine Trend

 ENDEAVOUR COMPLETES UPSIZE OF ITY CIL PLANT AND CONSOLIDATES THE ITY MINE TRENDHIGHLIGHTS:                                                  CIL Plant Upsize·CIL plant capacity increased by 25%, from 4Mtpa to 5Mtpa, completed on budget and on schedule·The plant has achieved an annualized throughput exceeding 5Mtpa for the past two weeksIty Trend Consolidation·Successfully consolidated the full 125km trend along the Ity Birimian belt with the acquisition of the Mahapleu tenement·The Mahapleu tenement hosts an intrusive anomaly which has the potential to be similar in type and size to the one occurring at the Ity mine complex  ·The Mahapleu tenement is now one of the highly ranked greenfield exploration licenses within Endeavour’s portfolio; ground surveys expected to be initiated in early 2020Abidjan, November 21, 2019 – Endeavour Mining...

Continue reading

Torex Gold Extends Mineralization Down-Dip at Sub-Sill

TORONTO, Nov. 21, 2019 (GLOBE NEWSWIRE) — Torex Gold Resources Inc. (the “Company” or “Torex”) (TSX: TXG) announces results from the 2019 drill program at the Sub-Sill deposit, at the Company’s El Limón Guajes complex in Mexico. The 2019 program successfully extended known mineralization 300 metres below existing reserves. Highlights from the latest round of drill results include 35.1 g/t Au over 6.1 metres in SST-156, 21.6 g/t Au over 3.5 metres in SST-135, 19.5 g/t Au over 5.9 metres in SST‑139, 15.7 g/t Au over 5.2 metres in SST-132, and 13.8 g/t Au over 12.8 metres in LDGU-047. Mineralization at Sub-Sill remains open at depth and along strike. Fred Stanford, President & CEO of Torex Gold, stated:“The down-dip extensions of the mineralization of both Sub-Sill and El Limón Deep (ELD), the latter highlighted in a press release...

Continue reading

Qutoutiao Inc. to Report Third Quarter 2019 Results on December 3, 2019

SHANGHAI, China, Nov. 21, 2019 (GLOBE NEWSWIRE) — Qutoutiao Inc. (“Qutoutiao” or the “Company”) (NASDAQ: QTT), a leading operator of mobile content platforms in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2019 before the open of U.S. market on December 3, 2019.Dial-in details for the live conference call are as follows:Additionally, a live and archived webcast of the conference call will be available on the Company’s investor relations website at https://ir.qutoutiao.net.About Qutoutiao Inc.Qutoutiao Inc. operates innovative and fast-growing mobile content platforms in China with a mission to bring fun and value to its users. The eponymous flagship mobile application, Qutoutiao, meaning “fun headlines” in Chinese, applies artificial intelligence-based algorithms...

Continue reading

Singleton McAllister Appointed to Chart Industries, Inc. Board of Directors

ATLANTA, Nov. 21, 2019 (GLOBE NEWSWIRE) — The Board of Directors of Chart Industries, Inc. (NASDAQ: GTLS) has appointed Singleton McAllister as a new director effective November 20, 2019.  Ms. McAllister will be a member of the Nominations and Governance Committee and the Compensation Committee, effective immediately.Ms. McAllister is an attorney with Husch Blackwell LLP and a member of its Technology, Manufacturing & Transportation section.  A leader in government affairs regulatory law for over 30 years, she has held several senior positions at the national level including senior counsel to the U.S. House of Representatives Committee on the Budget.  Ms. McAllister was appointed by then President Bill Clinton as the General Counsel to the U.S. Agency for International Development where she was the chief legal advisor to 72...

Continue reading

Red Pine Intersects Unexpected Gold Zones at the Wawa Gold Project – Highlights Include 2 g/t over 11.28m including 6.13 g/t over 3.15m

TORONTO, Nov. 21, 2019 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSX-V: RPX) (“Red Pine” or the “Company”) announces drill results from its Fall 2019 Drilling Program at the Wawa Gold Project, located near Wawa, Ontario. The Company discovered 3 new gold zones, located away from the Surluga Deposit (Figure 1). Highlights include a discovery east of the Surluga Deposit (footwall) of 2.00 g/t gold over 11.28 metres, including 6.13 g/t over 3.15 metres, and a discovery west of the Surluga Deposit (hanging wall) of 4.72 g/t over 2.77 metres and 5.13 g/t over 1.80 metres. Also, drilling below the existing Surluga Deposit intersected, as predicted, mineralization at depth.Quentin Yarie, Chief Executive Officer of Red Pine stated, “Our 2019 exploration results continue to successfully extend the Wawa Gold...

Continue reading

CytoDyn Reports Strong Positive Preclinical Data to Demonstrate Potential of Leronlimab in Treating Nonalcoholic Fatty Liver Disease (NAFLD) in Humanized Mouse Model

VANCOUVER, Washington, Nov. 21, 2019 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, today announced strong positive preclinical data highlighting the potential of leronlimab in treating nonalcoholic fatty liver disease (NAFLD), a common precursor to nonalcoholic steatohepatitis (NASH). These data, along with previous findings showing that leronlimab inhibits liver fibrosis, demonstrates the potential of leronlimab to control both the early and late stages of NASH.The study, in which immunodeficient, NOD-scid gamma (NSG) mice were fed a high fat, NASH-inducing diet, transplanted with human stem cells to repopulate the deficient immune system, and treated with...

Continue reading

Xeris Pharmaceuticals Provides a Business Update During Recent Investor Conference

MAA submitted to EMA of liquid stable glucagon for severe hypoglycemiaGVOKE™ PFS launch underwayGVOKE HypoPen™ expected to launch July 2020CHI program shifts to Expanded AccessHAAF program discontinued based on Phase 2 resultsCHICAGO, Nov. 21, 2019 (GLOBE NEWSWIRE) — Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that Paul R. Edick, Xeris’ Chairman and CEO, provided an update of its portfolio programs during a fireside chat at the Jefferies London Healthcare Conference. A replay of Mr. Edick’s remarks is available on the Company’s website.“Today I provided recent progress on several of our programs, including the submission of our MAA to the European Marketing...

Continue reading

Form 8.3 – Eland Oil & Gas plc

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.